Popular on TelAve
- OddsTrader Asks: What Are the Chances Your Team Makes the NFL Playoffs? - 824
- Zoiko Orbit Launches: Seamless Global Travel Connectivity in 200+ Countries, Including Africa - 616
- EMBER™, the Only Standardized System Linking Workforce Identity to Growth, Appoints Global Brand Visionary Bret Sanford-Chung to Board of Directors - 406
- Modernizing Pole Data Collection for Next-Gen Network Expansion - 392
- Phinge®, Home of Netverse® and Netaverse™ With Verified and Safer AI Announces "Test the Waters" Campaign for Potential Regulation A+ Offering - 389
- FreeTo.Chat Launches Silent Confessions, the Best Confession Site for Anonymous, Ad-Free Truth Sharing - 379
- Sober.Buzz Adds Second Podcast, "Spreading the Good BUZZ" Guest List Grows, Numbers Continue Growing Globally, All While Josh and Heidi Tied the Knot - 378
- Iterators Named Preferred Accessibility Testing Vendor by MIT - 377
- Contracting Resources Group Appears Again on the Inc. List of Fastest-Growing Companies - 365
- Assent Joins AWS ISV Accelerate Program - 365
Similar on TelAve
- Teaming Agreement with Emtel Energy USA to Advance Thin-Film PV Energy Storage Capabilities; NASA agreements for Solar Space Tech; Ascent Solar $ASTI
- From Tokyo to Berlin: FreeTo.Chat Unites Cultures with the World's First Confession VRX — EmojiStream™
- Elevate Unveils GroundComm X30 at 2025 International GSE Expo in Las Vegas
- Physician-Turned-Patient Launches Advocacy Campaign to Spotlight Disability Insurance Barriers
- Youth Take the Lead: Kopp Foundation for Diabetes Hosts "By Youth, For Youth, With T1D" Gala on October 8 at Blue Bell Country Club
- "Leading From Day One: The Essential Guide for New Supervisors" Draws from 25+ Years of International Management Experience
- New Slotozilla Project Explores What Happens When the World Goes Silent
- Albuquerque's Z-CoiL Footwear Brings All-American Family Business Story to Shark Tank Season Premiere
- Unicorp and BH Group Select Chasing Creative—Palm Coast Agency—to Lead Growth Marketing for The Ritz-Carlton Residences, Hammock Dunes
- SecureMaine 2025 is this October 8th in Portland, Maine
WesternU researchers show Osteopathic Manipulative Treatment improves efficacy of COVID-19 vaccine
TelAve News/10875547
POMONA, Calif., Sept. 15, 2025 ~ A recent study conducted by researchers from Western University of Health Sciences College of Osteopathic Medicine of the Pacific (COMP) and their colleagues has found that Osteopathic Manipulative Treatment (OMT) can enhance immune responses to COVID-19 vaccination.
The study, published in Virus Research, involved 104 participants who were randomly assigned to receive either a brief, five-minute lymphatic OMT protocol immediately after receiving the COVID-19 vaccine and the day after each dose, or usual care. The primary analysis was conducted on 51 participants who had not previously been infected with COVID-19.
The results showed that those who received OMT had higher levels of antibodies at three weeks and a greater overall antibody response through 13 weeks compared to those who received usual care. This was especially true for participants without a prior COVID-19 infection.
In addition, for those who did contract COVID-19 despite being vaccinated, the group that received OMT reported faster recovery times and less severe symptoms. On average, they experienced a shorter illness duration of 4.5 days compared to 8 days for those who did not receive OMT. They also used medication for fewer days (an average of 1.5 days versus 5 days).
More on TelAve News
"This study shows that there are ways we might be able to improve the response to a vaccination which could lead to better outcomes for patients," said COMP Professor and Chief Medical Officer of WesternU Health Medical Center Brian Loveless, DO '02, one of the co-authors of the study. "For physicians, this means that a simple intervention like OMT could potentially give their patients an improved response and better protection against infections."
The study's citation is Eric S. Martinez et al.'s "COVID-19 mRNA vaccine immune response to the addition of osteopathic manipulative treatment with lymphatic pumps: a randomized controlled trial" published in Virus Research in 2025.
The authors note that this was a pilot study and recommend larger, multi-center studies to confirm the generalizability of their findings. The study brought together physicians and scientists with backgrounds in osteopathic medicine, microbiology, pharmacology, and biostatistics.
"This was an exciting finding for me as a non-DO because I was able to support the DO philosophy and observations by creating a solid scientific protocol to demonstrate the verifiability of their claims," said COMP Associate Professor and co-first author of the study Sébastien Fuchs, MD, PhD. "The results show that OMT manipulation at the time of vaccination can improve its efficacy and protection against diseases. This is particularly important in improving population immunity."
More on TelAve News
The American Osteopathic Association President Robert Piccinini, DO, D.FACN also commented on the study's findings, stating that "OMT is a powerful, non-invasive intervention that can strengthen the body's immune response while promoting wellness and balance." He added that this research highlights the significance of OMT as a complementary treatment option for patients.
The American Osteopathic Foundation (AOF) also expressed their support for this study as one of its lead funders. AOF CEO Rita Forden stated that supporting scholarly research is a core priority for their organization and this study reflects the values of osteopathic medicine in promoting patient-centered care.
In conclusion, this groundbreaking study has shown that OMT can enhance immune responses to COVID-19 vaccination and potentially improve outcomes for patients. Further research is needed to confirm these findings on a larger scale.
The study, published in Virus Research, involved 104 participants who were randomly assigned to receive either a brief, five-minute lymphatic OMT protocol immediately after receiving the COVID-19 vaccine and the day after each dose, or usual care. The primary analysis was conducted on 51 participants who had not previously been infected with COVID-19.
The results showed that those who received OMT had higher levels of antibodies at three weeks and a greater overall antibody response through 13 weeks compared to those who received usual care. This was especially true for participants without a prior COVID-19 infection.
In addition, for those who did contract COVID-19 despite being vaccinated, the group that received OMT reported faster recovery times and less severe symptoms. On average, they experienced a shorter illness duration of 4.5 days compared to 8 days for those who did not receive OMT. They also used medication for fewer days (an average of 1.5 days versus 5 days).
More on TelAve News
- Matecrypt Observes South American Cryptocurrency Adoption Surge Amid Economic Shifts
- Assent Uncovers Over 695 Unique PFAS Across Global Supply Chains as Regulations Increase
- Cryptocurrency Quarterly Trading Volume Surpasses $15 Trillion Record High as BrazilNex Acknowledges Industry 'Growing Pains' Amid Market Speculation
- AHRFD Initiates Legal Proceedings Against Anwalt.de for Publishing Defamatory and False Content
- New Analysis Reveals the Complex Forces Driving the 'Great Human Reshuffle'
"This study shows that there are ways we might be able to improve the response to a vaccination which could lead to better outcomes for patients," said COMP Professor and Chief Medical Officer of WesternU Health Medical Center Brian Loveless, DO '02, one of the co-authors of the study. "For physicians, this means that a simple intervention like OMT could potentially give their patients an improved response and better protection against infections."
The study's citation is Eric S. Martinez et al.'s "COVID-19 mRNA vaccine immune response to the addition of osteopathic manipulative treatment with lymphatic pumps: a randomized controlled trial" published in Virus Research in 2025.
The authors note that this was a pilot study and recommend larger, multi-center studies to confirm the generalizability of their findings. The study brought together physicians and scientists with backgrounds in osteopathic medicine, microbiology, pharmacology, and biostatistics.
"This was an exciting finding for me as a non-DO because I was able to support the DO philosophy and observations by creating a solid scientific protocol to demonstrate the verifiability of their claims," said COMP Associate Professor and co-first author of the study Sébastien Fuchs, MD, PhD. "The results show that OMT manipulation at the time of vaccination can improve its efficacy and protection against diseases. This is particularly important in improving population immunity."
More on TelAve News
- Elevate Unveils GroundComm X30 at 2025 International GSE Expo in Las Vegas
- NEW power supply release from Kepco Dynatronix - HSP Advanced
- St. Augustine Honors Hispanic Heritage Month
- Vesica Health Receives AUA Guideline Inclusion
- Steward's Plumbing Sponsors the 2025 Samson Challenge, Bringing Community, Fitness, and Fun Together in Albuquerque
The American Osteopathic Association President Robert Piccinini, DO, D.FACN also commented on the study's findings, stating that "OMT is a powerful, non-invasive intervention that can strengthen the body's immune response while promoting wellness and balance." He added that this research highlights the significance of OMT as a complementary treatment option for patients.
The American Osteopathic Foundation (AOF) also expressed their support for this study as one of its lead funders. AOF CEO Rita Forden stated that supporting scholarly research is a core priority for their organization and this study reflects the values of osteopathic medicine in promoting patient-centered care.
In conclusion, this groundbreaking study has shown that OMT can enhance immune responses to COVID-19 vaccination and potentially improve outcomes for patients. Further research is needed to confirm these findings on a larger scale.
Filed Under: Business
0 Comments
Latest on TelAve News
- Green Office Partner Named #1 Best Place to Work in Chicago by Crain's for 2025
- CCHR, a Mental Health Watchdog Organization, Hosts Weekly Events Educating Citizens on Important Mental Health Issues
- Netverse Could Diminish the Reliance on Cyber Security Software & Companies Through its AI, Patented App-less Technologies & Phinge Mobile Hardware
- "Leading From Day One: The Essential Guide for New Supervisors" Draws from 25+ Years of International Management Experience
- New Slotozilla Project Explores What Happens When the World Goes Silent
- The Two Faces of Charles D. Braun: How the Novel, Posthumously Yours, Came to Life
- Counseling Center of New Smyrna Beach Expands Affordable Mental Health Services for Volusia County
- Athena Forge (ATFG) Introduces Advanced Token for Technology-Driven Financial Ecosystem
- Albuquerque's Z-CoiL Footwear Brings All-American Family Business Story to Shark Tank Season Premiere
- NoviSign Sponsoring VARTECH 2025 - the B2B IT channel's #1 event
- Unicorp and BH Group Select Chasing Creative—Palm Coast Agency—to Lead Growth Marketing for The Ritz-Carlton Residences, Hammock Dunes
- Breaking: 50+ runners from 20+ states relay custom 9/11 flag 485 miles from Shanksville through DC to Ground Zero for memorial remembrance run
- SecureMaine 2025 is this October 8th in Portland, Maine
- John Thomas calls for unity and prayer after tragic loss
- Where the Miami Dolphins Stand After Week 1
- Which NFL Teams Can Rebound from Week 1? OddsTrader Breaks Down the Biggest Questions
- Starlink Local Installers offers national Starlink installations!
- Apellix Deploys Breakthrough Spray-Painting Drones into Live Service Limited Beta Program Open for Advanced Contractors
- DivX Unveils New Educational Blog Series to Simplify MKV to MP4 Video Conversion
- Copper Mountain Technologies Introduces Affordable New VTR0102 and VTR0302 VNAs